Roughly one in six people with primary Sjögren’s syndrome tests negative on the standard blood panels doctors rely on most, a situation formally known as seronegative Sjögren’s. The blood tests in question look for specific antibodies called anti-SSA (also known as anti-Ro) and anti-SSB (anti-La), and their absence does not rule the disease out. The gap between what the blood work shows and what is actually happening in the body is one of the most frustrating aspects of this condition for patients and clinicians alike.
Why the Standard Blood Tests Miss Some Cases
The antibodies most strongly associated with Sjögren’s are anti-SSA/Ro and anti-SSB/La. When either is present, the diagnosis becomes much more straightforward. But the immune system’s attack on moisture-producing glands does not always generate these particular antibodies at detectable levels. Some patients with clear glandular damage, confirmed under a microscope, never produce them at all. A 2024 review described seronegative sicca syndrome as encompassing patients who present with dry eyes and dry mouth but lack anti-SSA/SSB antibodies and do not meet current classification criteria, even when their tissue samples show the same kind of immune-driven gland destruction seen in seropositive cases.1PubMed Central. Seronegative Sicca Syndrome: Diagnostic Considerations and Management Strategies
Current classification criteria for Sjögren’s use a weighted scoring system that gives heavy points to a positive anti-SSA/Ro result. That weighting makes the criteria very good at catching seropositive patients but creates a blind spot for those whose immune activity takes a different serological path. A 2025 review cautioned that over-reliance on serological markers, partly because blood tests are so easy to order, can contribute to missed diagnoses and that accurate identification requires flexible clinical reasoning beyond rigid adherence to classification criteria.2PubMed Central. From Sjögren syndrome to Sjögren disease: rethinking classification and diagnostic complexity
How Common Is Seronegative Sjögren’s
Studies consistently find that a substantial minority of confirmed Sjögren’s patients are seronegative, though the exact share depends on the population studied and the criteria used. In a Chinese cohort of 232 patients with primary Sjögren’s, about 17% were seronegative.3PubMed Central. Seronegative primary Sjögren’s syndrome, a distinct subtype of primary Sjögren’s syndrome in Chinese patients A study of 375 patients found that about 15.5% were seronegative for all four major autoantibodies, including antinuclear antibodies and rheumatoid factor on top of anti-Ro and anti-La.4PubMed. Clinical and serological characteristics of seronegative primary Sjögren’s syndrome: a comparative study A Turkish cohort of 273 patients reported a nearly identical figure of about 16.5%.5Turkish Journal of Immunology. Is There a Need for Such a Naming: Seronegative Primary Sjogren’s Syndrome?
Across the broader literature, estimates range from about 8% to 37% of Sjögren’s cohorts, with the variation driven by how strictly seronegativity is defined and whether additional antibody tests beyond the classic panel are included. In a large real-world registry of over 1,300 patients who had both anti-SSA/Ro and anti-SSB/La testing, about 6% were negative for both, while 69% were positive for both.6PubMed Central. Real-World Assessment of Systemic Disease Activity in Seropositive and Seronegative Patients with Sjögren’s Disease and Association with Patient-Reported Outcomes That lower figure likely reflects the fact that registry populations often lean toward patients who already had positive blood work and received a clear-cut diagnosis, making it harder for seronegative patients to be counted in the first place.
The Role of Lip Biopsy
When blood tests come back negative but suspicion remains high, the most definitive next step is a minor salivary gland biopsy, typically taken from the inside of the lower lip. A pathologist examines the tissue for clusters of immune cells called lymphocytic foci. If at least one cluster of 50 or more lymphocytes appears in a 4-square-millimeter area, the “focus score” is considered positive, and that carries substantial weight toward a diagnosis.
For seronegative patients, the biopsy is often the key that unlocks the diagnosis. The 375-patient study mentioned earlier diagnosed all of its seronegative cases on the basis of lymphocytic infiltration found in lip biopsy samples.4PubMed. Clinical and serological characteristics of seronegative primary Sjögren’s syndrome: a comparative study A case report from 2024 described how the focus score from a labial biopsy, combined with the clinical picture, was the deciding factor in establishing a seronegative diagnosis.7Bulletin of the National Research Centre. Labial salivary gland biopsy: a crucial method for confirming seronegative Sjogren’s syndrome—a case report A neurological study echoed this, urging clinicians to maintain a high degree of suspicion for seronegative Sjögren’s and to consider the biopsy to avoid delaying diagnosis, since undertreatment affects quality of life.8PubMed Central. Neurologic involvement in seronegative primary Sjögren’s syndrome with positive minor salivary gland biopsy: a single-center experience
The biopsy is a minor outpatient procedure, typically done under local anesthesia, and most patients recover within a week. The main risk is temporary numbness at the biopsy site. It is not a test that most doctors order casually, though, which is part of why seronegative patients can wait years for answers. Many general practitioners and even some rheumatologists default to blood tests alone and stop investigating when those come back clean.
Why Ultrasound Falls Short in Seronegative Cases
Salivary gland ultrasound has gained traction as a noninvasive tool for evaluating Sjögren’s. It can pick up structural changes in the parotid and submandibular glands, like the characteristic inhomogeneous pattern caused by inflammation. But its performance in the seronegative subgroup is distinctly worse. A study evaluating two widely used ultrasound scoring systems in suspected Sjögren’s patients found that one score had high sensitivity but extremely low specificity, while the other had high specificity but detected only about 6% of positive cases. Neither ultrasound score showed a statistically significant association with biopsy results in the seronegative population.9Rheumatology. Diagnostic utility of major salivary gland ultrasonography in patients with suspected primary Sjögren’s syndrome
The upshot is that a normal-looking ultrasound does not meaningfully lower the chances that a seronegative patient actually has Sjögren’s. The biopsy remains the gold standard for this group, and ultrasound should not be treated as a substitute.
What Seronegative Sjögren’s Feels Like
One of the more surprising findings in the research is that seronegative patients are not necessarily better off just because their blood work looks calmer. In fact, some studies suggest they feel worse in certain respects. A comparison of seropositive and seronegative Sjögren’s patients found that the seronegative group reported greater fatigue, more pain interference with daily activities, and higher average pain intensity, along with lower physical function scores.10PubMed Central. Pain Severity and Neuropathic Pain symptoms in primary Sjogren’s syndrome: A comparison study of seropositive and seronegative Sjogren’s syndrome
The registry data on symptom frequency tells a slightly different story at the population level. Among double-seropositive patients, dry eyes were reported by 94% and physical fatigue by 82%. Among double-seronegative patients, those numbers were 74% and 60%, respectively.6PubMed Central. Real-World Assessment of Systemic Disease Activity in Seropositive and Seronegative Patients with Sjögren’s Disease and Association with Patient-Reported Outcomes So seronegative patients still experience the hallmark dryness and exhaustion at high rates, even if the overall percentages are somewhat lower. The Chinese cohort study found that seronegative patients tended to be older and had higher rates of dry mouth and dry eyes compared to the seropositive group, though their systemic disease activity scores were generally lower.3PubMed Central. Seronegative primary Sjögren’s syndrome, a distinct subtype of primary Sjögren’s syndrome in Chinese patients
The disconnect between blood markers and symptom burden is worth emphasizing. If you are living with crushing fatigue and sandpaper-dry eyes, a negative antibody test does not mean you are imagining things. It means the standard test missed you.
Measuring Dryness Objectively
Part of building a case for seronegative Sjögren’s involves documenting that dryness is real and measurable, not just a subjective complaint. Several objective tests can help.
For dry eyes, the Schirmer test measures tear production by placing a small strip of filter paper under the lower eyelid for five minutes. Low readings point to aqueous-deficient dry eye, the type most associated with Sjögren’s. Ocular surface staining, where a dye is applied to the eye and damage to the cornea and conjunctiva is graded under a special light, adds another layer of evidence.11PubMed Central. Making the diagnosis of Sjögren’s syndrome in patients with dry eye
For dry mouth, salivary flow rate testing collects saliva over a set period. A study of over 100 Sjögren’s patients found that unstimulated whole salivary flow was decreased in about 82% and stimulated flow was decreased in about 87%, with more than a third of patients unable to produce any measurable unstimulated saliva at all.12PubMed Central. Stimulated whole salivary flow rate: The most appropriate technique for assessing salivary flow in Sjögren syndrome Research has suggested that raising the unstimulated flow threshold used for screening might improve its ability to catch Sjögren’s cases.13PubMed Central. Unstimulated whole saliva flow for diagnosis of primary Sjögren’s syndrome: time to revisit the threshold? A systematic review found that while unstimulated salivary flow rate had good sensitivity, it had low specificity compared to the lip biopsy, meaning that a low flow rate can point in the right direction but does not seal the diagnosis on its own.14PubMed Central. A systematic review of methods to diagnose oral dryness and salivary gland function
These tests matter for seronegative patients because they provide the objective documentation that classification criteria demand. You can lack every antibody and still accumulate enough points from a positive biopsy and abnormal dryness tests to meet the diagnostic threshold, or at least give your rheumatologist enough evidence to treat you.
Other Conditions That Look Like Sjögren’s
Before settling on seronegative Sjögren’s as the explanation, a doctor should rule out other causes of chronic dryness. The differential diagnosis is broader than most patients realize. A comprehensive review identified the most common alternative diagnoses as other systemic autoimmune diseases, idiopathic sicca syndrome (dry eyes and mouth with no identifiable autoimmune cause), and drug-induced dryness. But the list also includes sarcoidosis, IgG4-related disease, chronic hepatitis C, HIV infection, graft-versus-host disease, and prior head and neck radiation therapy, each of which requires very different management.15PubMed. The Differential Diagnosis of Dry Eyes, Dry Mouth, and Parotidomegaly: A Comprehensive Review
Medications are an underappreciated culprit. Antidepressants, antihistamines, blood pressure drugs, and many other commonly prescribed medications can dry out the eyes and mouth substantially. If you are on one or more of these medications and your blood tests are negative, the dryness could be pharmaceutical rather than autoimmune. Your doctor should assess whether symptoms predated the medication or worsened after starting it.
Antibodies Can Show Up Later
An intriguing wrinkle in the seronegative story is that some patients who initially test negative eventually seroconvert, meaning the antibodies appear months or years after the first test. A case report of a three-year-old girl with juvenile Sjögren’s illustrates this strikingly. At presentation, her blood work was negative for anti-Ro, anti-La, and rheumatoid factor. Two years later, repeated testing showed positive seroconversion for both anti-Ro and anti-La. The authors noted that about 29% of patients with primary Sjögren’s can present seronegative for anti-Ro and about 33% for anti-La, and recommended periodic retesting of seronegative patients with a suspected diagnosis.16Open Access Rheumatology: Research and Reviews. Primary Juvenile Sjögren’s Syndrome in a 3-Year-Old Pediatric Female Patient: Diagnostic Role of Salivary Gland Ultrasonography: Case Report
This finding has practical implications for adults, too. If you tested negative once and your symptoms persist or worsen, it is reasonable to ask your doctor about repeating the antibody panel. The immune response can evolve, and a test that was negative three years ago may not stay that way.
New Biomarkers Under Investigation
Researchers are actively hunting for blood markers that could catch the patients the current tests miss. Two recent efforts stand out.
A 2025 study developed panels of novel autoantibodies specifically aimed at detecting anti-Ro/SSA-negative Sjögren’s patients. A five-marker panel including antibodies against proteins called FNBP4, SNRPC, CCL4, M3, and KDM6B achieved a sensitivity of up to 46% with 95% specificity for distinguishing Sjögren’s patients from healthy controls. That sensitivity is not high enough to serve as a standalone screening test, but it represents a meaningful step toward identifying patients who would otherwise be invisible to standard panels.17PubMed Central. Identification of novel autoantibodies in Sjögren’s disease
Another study took a different approach, identifying antibodies against a protein called DTD2 that were significantly more common in anti-SSA-negative Sjögren’s patients than in controls with sicca symptoms from other causes. When incorporated into a predictive model alongside clinical variables, these markers discriminated between Sjögren’s and non-Sjögren’s dryness with reasonable accuracy.18PubMed Central. Novel autoantibodies help diagnose anti-SSA antibody negative Sjögren disease and predict abnormal labial salivary gland pathology
Neither of these panels is available in routine clinical practice yet. But they signal a future where the diagnostic net for Sjögren’s is wider, and fewer patients fall through it simply because their immune system does not produce the “expected” antibodies.
Getting Treated Without a Textbook Diagnosis
A persistent worry for seronegative patients is whether they will receive adequate treatment if their diagnosis is uncertain or informal. The reassuring reality is that treatment for Sjögren’s is largely symptom-driven rather than antibody-driven. Artificial tears, saliva substitutes, and prescription eye drops that reduce ocular surface inflammation work the same way regardless of blood test results. For more aggressive systemic symptoms, immunosuppressive medications can also be effective in seronegative patients. A case report described significant improvement in dry mouth and normalization of elevated immunoglobulin levels in a seronegative patient treated with tacrolimus, an immunosuppressive drug, after steroids proved inadequate.19PubMed Central. Treatment of serologically negative Sjögren’s syndrome with tacrolimus: A case report
If you are caught in the frustrating space between clearly abnormal symptoms and a noncommittal blood test, push for the objective dryness tests and, if appropriate, a lip biopsy. A rheumatologist experienced with Sjögren’s is more likely to pursue these steps than a generalist who views negative antibodies as the end of the road. Patient advocacy organizations for Sjögren’s maintain directories of knowledgeable specialists, which can save months or years of bouncing between providers who are not looking for seronegative disease.
The Testing Gap in Children
Sjögren’s is rare in children, but when it does occur, diagnosis is even harder than in adults. Kids often present with atypical symptoms, reliable symptom histories are difficult to obtain from young children, and no pediatric-specific classification criteria exist. Adult criteria are applied by default, and they frequently do not capture the disease at its earliest stages in a child. The pediatric case described above, where a young girl was seronegative at diagnosis and seroconverted only two years later, highlights how the diagnostic timeline in children can stretch out considerably.16Open Access Rheumatology: Research and Reviews. Primary Juvenile Sjögren’s Syndrome in a 3-Year-Old Pediatric Female Patient: Diagnostic Role of Salivary Gland Ultrasonography: Case Report For parents navigating unexplained dryness, swollen glands, or recurrent parotitis in a child, awareness that negative blood work does not exclude Sjögren’s is particularly important.
Antibody testing is sometimes more nuanced than a simple positive or negative. Some assays detect only anti-Ro60, while others detect both anti-Ro52 and anti-Ro60. A patient who tests negative on one platform might test positive on another that captures a different antigen. A case report described a patient positive for isolated anti-Ro52 by one method and positive on a broader assay that recognizes both Ro52 and Ro60, illustrating how the choice of test kit affects results.20PubMed Central. Sjögren’s syndrome positive for isolated anti-Ro52/SS-A antibody and anti-centromere antibody If your symptoms are strongly suggestive and a basic antibody panel came back negative, it is worth asking which specific assay was used and whether more sensitive testing is available.